UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 366

Sortiert nach

Prediction of Oral Drug Absorption in Rats from In Vitro Data

Pharmaceutical research, 2023-02, Vol.40 (2), p.359-373

2023

Volltextzugriff (PDF)

Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs

Pharmaceutics, 2020-09, Vol.12 (9), p.844

2020

Volltextzugriff (PDF)

Prediction Accuracy of Mechanism-Based Oral Absorption Model for Dogs

Journal of pharmaceutical sciences, 2019-08, Vol.108 (8), p.2728-2736

2019

Volltextzugriff (PDF)

Evaluation of Using Dogs to Predict Fraction of Oral Dose Absorbed in Humans for Poorly Water-Soluble Drugs

Journal of pharmaceutical sciences, 2018-09, Vol.107 (9), p.2489-2496

2018

Volltextzugriff (PDF)

Prediction Characteristics of Oral Absorption Simulation Software Evaluated Using Structurally Diverse Low-Solubility Drugs

Journal of pharmaceutical sciences, 2020-03, Vol.109 (3), p.1403-1416

2020

Volltextzugriff (PDF)

A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension

PloS one, 2014-04, Vol.9 (4), p.e93230

2014

Volltextzugriff (PDF)

A new CysLT1 and CysLT2 receptors-mediated anaphylaxis guinea pig model

Prostaglandins, leukotrienes and essential fatty acids, 2017-04, Vol.119, p.18-24

2017

Volltextzugriff (PDF)

Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma

Journal of medicinal chemistry, 2015-08, Vol.58 (15), p.6093-6113

2015

Volltextzugriff (PDF)

Development of Mice Exhibiting Hepatic Microsomal Activity of Human CYP3A4 Comparable to That in Human Liver Microsomes by Intravenous Administration of an Adenovirus Vector Expressing Human CYP3A4

Drug metabolism and pharmacokinetics, 2014, Vol.29 (4), p.296-304

2014

Volltextzugriff (PDF)

Development of Mice Exhibiting Hepatic Microsomal Activity of Human CYP3A4 Comparable to That in Human Liver Microsomes by Intravenous Administration of an Adenovirus Vector Expressing Human CYP3A4

DRUG METABOLISM AND PHARMACOKINETICS, 2014-08, Vol.29 (4), p.296-304

2014

Volltextzugriff (PDF)

Hybrid CRP Propulsion System for ROPAX Ferries

Marine Engineering, 2020/09/01, Vol.55(5), pp.567-572

2020

Volltextzugriff (PDF)

Hybrid CRP Propulsion System for ROPAX Ferries

Marin Enjiniaringu, 2020-09, Vol.55 (5), p.567-572

2020

Volltextzugriff (PDF)

Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs

European journal of pharmacology, 2015-05, Vol.754, p.98-104

2015

Volltextzugriff (PDF)

Pyrazolo[1,5- a]pyrimidines, triazolo[1,5- a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF 1) receptor antagonists

Bioorganic & medicinal chemistry, 2011-10, Vol.19 (20), p.5955-5966

2011

Volltextzugriff (PDF)

ONO-8430506: A Novel Autotaxin Inhibitor That Enhances the Antitumor Effect of Paclitaxel in a Breast Cancer Model

ACS medicinal chemistry letters, 2020-06, Vol.11 (6), p.1335-1341

2020

Volltextzugriff (PDF)

Harmonizing solubility measurement to lower inter-laboratory variance - progress of consortium of biopharmaceutical tools (CoBiTo) in Japan

ADMET & DMPK, 2019-01, Vol.7 (3), p.183-195

2019

Volltextzugriff (PDF)

Discovery of a potent, orally available dual CysLT1 and CysLT2 antagonist with dicarboxylic acid

Bioorganic & medicinal chemistry, 2015-05, Vol.23 (9), p.2079-2097

2015

Volltextzugriff (PDF)

フェリーにおけるハイブリッドＣＲＰ推進システム

マリンエンジニアリング, 2020/09/01, Vol.55(5), pp.567-572

2020

Volltextzugriff (PDF)

Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF1) receptor antagonists

Bioorganic & medicinal chemistry, 2012-01, Vol.20 (2), p.1122-1138

2012

Volltextzugriff (PDF)

6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonists

Bioorganic & medicinal chemistry, 2011-09, Vol.19 (18), p.5432-5445

2011

Volltextzugriff (PDF)

Discovery of Gemilukast (ONO-6950), a Dual CysLT 1 and CysLT 2 Antagonist As a Therapeutic Agent for Asthma

Journal of medicinal chemistry, 2015-08, Vol.58 (15), p.6093-6113

2015

Volltextzugriff (PDF)

Development of Disk Type Underwater Glider for Virtual Mooring: Part 5, Research on Course Control

Journal of the Japan Society of Naval Architects and Ocean Engineers, 2017, Vol.26, pp.213-223

2017

Volltextzugriff (PDF)

Development of Disk Type Underwater Glider for Virtual Mooring: Part 5, Research on Course Control

Nihon Senpaku Kaiyō Kōgakkai ronbunshū, 2017, Vol.26, p.213-223

2017

Volltextzugriff (PDF)

A new CysLT 1 and CysLT 2 receptors-mediated anaphylaxis guinea pig model

Prostaglandins, leukotrienes and essential fatty acids, 2017-04, Vol.119, p.18

2017

Volltextzugriff (PDF)

Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF1) receptor antagonists: Symposium-in-Print: Chemical Proteomics

Bioorganic & medicinal chemistry, 2012, Vol.20 (2), p.1122-1138

2012

Volltextzugriff (PDF)

1 – 25 von 366

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(297)
Mit Volltextzugriff
(338)

Publikationsform

Sprache

Englisch
(331)
Japanisch
(124)

Erscheinungsjahr

n.n

Thema

Science & Technology
(219)
Life Sciences & Biomedicine
(166)
Humans
(115)
Male
(62)
Female
(41)
Middle Aged
(40)
Gastroenterology & Hepatology
(38)
Animals
(34)
Physical Sciences
(34)
Aged
(31)
Science & Technology - Other Topics
(29)
Adult
(26)
Biological And Medical Sciences
(26)
Multidisciplinary Sciences
(25)
Chemistry
(24)
Medical Sciences
(23)
Patients
(22)
Medicine
(21)
Retrospective Studies
(20)
Mutation
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Prediction of Oral Drug Absorption in Rats from In Vitro Data

Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs

Prediction Accuracy of Mechanism-Based Oral Absorption Model for Dogs

Evaluation of Using Dogs to Predict Fraction of Oral Dose Absorbed in Humans for Poorly Water-Soluble Drugs

Prediction Characteristics of Oral Absorption Simulation Software Evaluated Using Structurally Diverse Low-Solubility Drugs

A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension

A new CysLT1 and CysLT2 receptors-mediated anaphylaxis guinea pig model

Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma

Development of Mice Exhibiting Hepatic Microsomal Activity of Human CYP3A4 Comparable to That in Human Liver Microsomes by Intravenous Administration of an Adenovirus Vector Expressing Human CYP3A4

Development of Mice Exhibiting Hepatic Microsomal Activity of Human CYP3A4 Comparable to That in Human Liver Microsomes by Intravenous Administration of an Adenovirus Vector Expressing Human CYP3A4

Hybrid CRP Propulsion System for ROPAX Ferries

Hybrid CRP Propulsion System for ROPAX Ferries

Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs

Pyrazolo[1,5- a]pyrimidines, triazolo[1,5- a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF 1) receptor antagonists

ONO-8430506: A Novel Autotaxin Inhibitor That Enhances the Antitumor Effect of Paclitaxel in a Breast Cancer Model

Harmonizing solubility measurement to lower inter-laboratory variance - progress of consortium of biopharmaceutical tools (CoBiTo) in Japan

Discovery of a potent, orally available dual CysLT1 and CysLT2 antagonist with dicarboxylic acid

フェリーにおけるハイブリッドＣＲＰ推進システム

Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF1) receptor antagonists

6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonists

Discovery of Gemilukast (ONO-6950), a Dual CysLT 1 and CysLT 2 Antagonist As a Therapeutic Agent for Asthma

Development of Disk Type Underwater Glider for Virtual Mooring: Part 5, Research on Course Control

Development of Disk Type Underwater Glider for Virtual Mooring: Part 5, Research on Course Control

A new CysLT 1 and CysLT 2 receptors-mediated anaphylaxis guinea pig model

Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF1) receptor antagonists: Symposium-in-Print: Chemical Proteomics

Suchergebnisse filtern